114
Participants
Start Date
February 28, 2025
Primary Completion Date
August 31, 2029
Study Completion Date
August 31, 2029
Standard Medical Therapy
"Intravenous doublet chemotherapy FOLFIRI or FOLFIRINOX + targeted systemic therapy (anti-EGFR or anti-VEGF).~Administered every 2 weeks for 12 cycles. Dosage and administration at recommended doses."
PIPAC
"In addition to standard systemic treatment, patients receive also four PIPAC procedures with pressurized aerosol containing oxaliplatin.~The PIPAC procedure is repeated up to a maximum of 4 times every 6 weeks."
APHM La Timone, Marseille
Centre François Baclesse, Caen
Centre Georges François Leclerc, Dijon
Institut de Cancérologie de Montpellier (ICM), Montpellier
Institut de Cancérologie de l'Ouest - Saint Herblain, Saint-Herblain
Institut de Cancérologie de Lorraine (ICL), Vandœuvre-lès-Nancy
CHU, Lille
Centre Hospitalier TARBES, Tarbes
CHRU, Strasbourg
Hospices Civils de Lyon - Hôpital Lyon Sud, Pierre-Bénite
APHP Saint Louis, Paris
APHP Hôpital Européen Georges Pompidou, Paris
CHU Dupuytren, Limoges
Hôpital d'Instruction des Armées Bégin, Saint-Mandé
Gustave Roussy, Villejuif
Institut Cancerologie de l'Ouest
OTHER